Canadian reactor to reopen

A linkurl:shuttered;http://www.the-scientist.com/blog/display/54006/ Canadian nuclear reactor that normally produces radioisotopes crucial to a variety of medical diagnoses will reopen soon. Emergency legislation linkurl:passed;http://www.thestar.com/News/Canada/article/285209 by the Canadian government late Tuesday (Dec 11) will allow the reactor to open for 120 days and resume production of the isotopes. Canada's Prime Minister, Stephen Harper, was apparently none too happy with the parties

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A linkurl:shuttered;http://www.the-scientist.com/blog/display/54006/ Canadian nuclear reactor that normally produces radioisotopes crucial to a variety of medical diagnoses will reopen soon. Emergency legislation linkurl:passed;http://www.thestar.com/News/Canada/article/285209 by the Canadian government late Tuesday (Dec 11) will allow the reactor to open for 120 days and resume production of the isotopes. Canada's Prime Minister, Stephen Harper, was apparently none too happy with the parties involved in the reactor's closing. "I can certainly assure the House that when this is all behind us," Harper told the __Toronto Star__, "the government will carefully examine the role of all actors in this incident and make sure that accountability is appropriately restored." The reactor's prolonged closure has caused a shortage of the isotope technetium-99 in hospitals, where it is used to diagnose cancers, heart and kidney problems among other ailments. Scientists I've contacted who use technetium-99 in their research have not yet experienced interruptions to their work. The company that operates the reactor originally linkurl:estimated;http://www.newscientist.com/article/dn13025-nuclear-plant-shutdown-brings-hospital-delays.html that the reactor would not reopen until January, 2008.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide